Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease. (2017)

First Author: Kotz D
Attributed to:  The UK Centre for Tobacco and Alcohol Studies (UKCTAS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2017-210067

PubMed Identifier: 28473506

Publication URI: http://europepmc.org/abstract/MED/28473506

Type: Journal Article/Review

Volume: 72

Parent Publication: Thorax

Issue: 10

ISSN: 0040-6376